Story
AeroVironment Stock Slides After RBC Capital Downgrade

Summary
Shares of the unmanned aircraft systems maker fell after RBC Capital downgraded the stock to 'Sector Perform,' citing a near-term end to its recent rally. Lingering legal issues and a broader market downturn are also weighing on the stock.
Shares of AeroVironment (NASDAQ: AVAV) fell on Tuesday after RBC Capital downgraded the stock, suggesting a recent rally following the company's Investor Day may have run its course. The move reflects a broader recalibration of analyst expectations for the defense technology firm.
Analyst Actions Temper Outlook
RBC Capital cut its rating on AeroVironment to Sector Perform from Outperform and lowered its price target to $180 from $210. According to the firm, the stock's strong performance following its recent earnings report and Investor Day event may be fully priced in for the near term.
Adding to the cautious sentiment, Piper Sandler, while maintaining its Overweight rating, also trimmed its price target on the shares to $235 from a previous $248.
Long-Term Guidance and Lingering Headwinds
The analyst actions followed AeroVironment's July 8 Investor Day, where management presented an ambitious long-term growth outlook. Key financial targets included:
Ad- Fiscal 2027 revenue guidance of $2.125 billion to $2.225 billion
- Fiscal 2030 revenue target of $3.5 billion to $4.0 billion
Despite the optimistic long-term forecast, the company continues to face significant headwinds. A persistent overhang on the stock includes multiple securities class action lawsuits tied to the cancellation of its SCAR Space Force contract and a June accounting restatement, which revealed an $89.4 million understatement of operational losses.
Market Reaction
The stock reversed sharply from its opening price of $165.67 to trade around $157.50 in pre-open trading. The decline was compounded by a soft broader market, with the S&P 500 and Dow Jones Industrial Average also trading lower.
The price action underscores the significant volatility the shares have undergone, with a 52-week range between $135.20 and $417.86.